Flexible dosing is now approved for Suvaxyn PCV2, porcine circovirus type 2 vaccine. Manufactured by Fort Dodge Animal Health, the vaccine can be used in pigs as young as 3 weeks of age.

The vaccine is designed to allow for the most appropriate vaccination protocol for specific production systems. USDA’s approval allows producers to vaccinate using a single 2-mL dose in pigs 3 weeks of age or older. Another option is to vaccinate pigs with two, 1-mL doses, the first dose being administered at 3 weeks of age or older and the second dose three weeks later.

“We know that many factors affect the success of any vaccination program,” says Dan Ellsworth, senior product manager, Fort Dodge Animal Health. “Changes in pig flow, viral load, maternal antibody levels and many other elements in day-to-day pork production can hamper a vaccine’s protection of individual pigs. By allowing pork producers and veterinarians to determine both the timing and number of doses with Suvaxyn PCV2, they have significantly more control over vaccine-triggered immunity.”

Suvaxyn PCV2 vaccine helps prevent PCV2 viremia and control lymphoid (immune system) depletion caused by PCV2. Data approved by USDA indicate Suvaxyn PCV2 vaccine provides four months of protection against PCVAD.

For more information, click here.